Accueil
Atlas
Analyses
Documentation
Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

ILRI-Genomics-Platform/SARS-CoV-2-intrahost-genetic-evolution: v1.0.0

Type de record:

software

Créateur:

Ken

Éditeur:

Zenodo

Hôte:

Analysis code for assessment of SARS-CoV-2 genetic evolution in Kenya

Visit

Licenses

Creative Commons Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/legalcode

Similaires

Genetic diversity and evolution of SARS-CoV-2 in the republic of Niger over 3 yearsGenomic Surveillance of SARS-CoV-2 in Ghana: Leveraging an Integrated National Influenza and SARS-CoV-2 PlatformCharacterization of SARS-CoV-2 genetic evolution in vaccinated and non-vaccinated patients from the Kenyan populationGenetic dynamics of HIV-1 : recombination, drug resistance and intrahost evolutionTable_2_SAS: A Platform of Spike Antigenicity for SARS-CoV-2.xlsxTable_3_SAS: A Platform of Spike Antigenicity for SARS-CoV-2.xlsx

Genetic diversity and evolution of SARS-CoV-2 in the republic of Niger over 3 years

Genomic Surveillance of SARS-CoV-2 in Ghana: Leveraging an Integrated National Influenza and SARS-CoV-2 Platform

Characterization of SARS-CoV-2 genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population

Abstract Vaccination is a key control measure of COVID-19 by preventing severe effects of

Genetic dynamics of HIV-1 : recombination, drug resistance and intrahost evolution

A striking characteristic of HIV is the enormous capacity of genetic variation. Frequent mutation

Table_2_SAS: A Platform of Spike Antigenicity for SARS-CoV-2.xlsx

Since the outbreak of SARS-CoV-2, antigenicity concerns continue to linger with emerging mutants.

Table_3_SAS: A Platform of Spike Antigenicity for SARS-CoV-2.xlsx

Since the outbreak of SARS-CoV-2, antigenicity concerns continue to linger with emerging mutants.